Solbar capitalises on cosmeceutical boom

Published: 20-Mar-2008

Solbar Plant Extracts has a number of new products for the global cosmeceuticals market, encouraged by widespread predictions of growth for the sector.

Solbar Plant Extracts has a number of new products for the global cosmeceuticals market, encouraged by widespread predictions of growth for the sector.

Solbar’s range of Solgen natural soy isoflavone extracts, designed for both topical and internal applications, are phytoestrogens structurally and functionally similar to oestrogen. Clinical research has shown that these can act as age defying ingredients, not only helping in various conditions from hot flushes to osteoporosis, but also to help recover and reinforce skin elasticity and improve antioxidant activity.

Phytoestrogens have also demonstrated synergistic benefits when used in conjunction with other ingredients, a factor Solbar sees as significant in the modern cosmetics industry. "We believe the age of single ingredients as an end to all problems is past, with responsible suppliers discovering the benefits of comprehensive synergistic properties of multiple actives,” commented Gary Brenner, Solbar's vp marketing and development. “Our focus on cosmeceuticals applications will take this approach into consideration.”

You may also like